| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Rheumatology 2002; 41: 787-792
© 2002 British Society for Rheumatology
Original Papers |
Role of cholecystokinin-8 in nerve growth factor and nerve growth factor mRNA expression in carrageenan-induced joint inflammation in adult rats
1 Institute of Neurobiology and Molecular Medicine, CNR, Viale Marx 15, 00137 Rome, Italy and
2 Department of Physiology and Pharmacology, Karolinska Institute, S17177 Stockholm, Sweden
Objectives. The aim of our study was to investigate the role of cholecystokinin-8 (CCK-8), which is able to induce the synthesis of nerve growth factor (NGF), in the joint inflammation of carrageenan-injected rats.
Methods. Adult rats were injected in the ankle joint with carrageenan, with or without CCK-8 or a CCK receptor antagonist (proglumide), and tissue swelling, NGF levels and NGF mRNA expression were assessed.
Results. Expression of NGF and NGF mRNA increased transiently after carrageenan injection. This effect was not altered by CCK-8 injection but was inhibited by the CCK receptor antagonist. The decrease in NGF level after treatment with the antagonist was concurrent with an increase in paw swelling.
Conclusions. The results demonstrate that, whereas CCK-8 has no anti-inflammatory action in carrageenan-injected animals, proglumide induces a worsening of inflammation and reduces the expression of both NGF and NGF mRNA in inflamed ankle joints. Our data point to a regulatory action of CCK-8 on NGF synthesis during acute synovitis and suggest a role for NGF in the healing phase of inflammation.
KEY WORDS: Arthritis, Carrageenan, Cholecystokinin-8, Nerve growth factor, Rats.
Correspondence to: L. Aloe, Institute of Neurobiology (CNR), Viale C. Marx 15-43, 00137 Rome, Italy.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
P. Xu, C. Van Slambrouck, L. Berti-Mattera, and A. K. Hall Activin Induces Tactile Allodynia and Increases Calcitonin Gene-Related Peptide after Peripheral Inflammation J. Neurosci., October 5, 2005; 25(40): 9227 - 9235. [Abstract] [Full Text] [PDF] |
||||
